Nagashima et al proposed a staging system for patients with colorectal carcinoma metastatic to the liver. The authors are from Teikyo University and University of Tokyo in Japan.
Patient selection: metastatic colorectal carcinoma to the liver undergoing partial hepatectomy
Parameters:
(1) number of colorectal metastases
(2) diameter of metastasis in cm
(3) extrahepatic metastases
(4) resectability
Number of Metastases |
Diameter in cm |
H code |
1 |
<= 5 cm |
H1 |
1 |
> 5 cm |
H2 |
>= 2 |
<= 5 cm |
H2 |
>= 2 |
> 5 cm |
H3 |
Extrahepatic Metastasis |
Resectability |
M code |
absent |
NA |
M0 |
present |
resectable |
M1 |
present |
unresectable |
not given |
H code |
M code |
Stage |
H1 |
M0 |
I |
H1 |
M1 |
II |
H2 |
M0 |
II |
H2 |
M1 |
III |
H3 |
M0 |
III |
H3 |
M1 |
IV |
NA |
unresectable |
IVb |
Stage |
5-Year Survival |
I |
75% |
II |
43% |
III |
< 10% |
IV |
0% at 10 months |
Specialty: Hematology Oncology, Surgery, general